{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:09:11Z","timestamp":1771060151599,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Individuals diagnosed with Fanconi anemia (FA), an uncommon disorder characterized by chromosomal instability affecting the FA signaling pathway, exhibit heightened vulnerability to the onset of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Herein, we employed diverse bioinformatics and statistical analyses to investigate the potential associations between the expression\/mutation patterns of FA pathway genes and MDS\/AML.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study included 4295 samples, comprising 3235 AML and 1024 MDS from our and nine other online cohorts. We investigated the distinct proportion of race, age, French-American-British, and gender factors. Compared to the FA wild-type group, we observed a decrease in the expression of FNACD2, FANCI, and RAD51C in the FA mutation group. The FA mutation group exhibited a more favorable clinical overall survival prognosis. We developed a random forest classifier and a decision tree based on FA gene expression for cytogenetic risk assessment. Furthermore, we created an FA-related Nomogram to predict survival rates in AML patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This investigation facilitates a deeper understanding of the functional links between FA and MDS\/AML.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01730-5","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T08:02:34Z","timestamp":1700121754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia"],"prefix":"10.1186","volume":"16","author":[{"given":"Lixian","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beibei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"issue":"6","key":"1730_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrm.2016.48","volume":"17","author":"R Ceccaldi","year":"2016","unstructured":"Ceccaldi R, Sarangi P, D'Andrea AD. The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol. 2016;17(6):337\u201349.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"1730_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.blre.2016.10.002","volume":"31","author":"NE Mamrak","year":"2017","unstructured":"Mamrak NE, Shimamura A, Howlett NG. Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia. Blood Rev. 2017;31(3):93\u20139.","journal-title":"Blood Rev"},{"issue":"5","key":"1730_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.molcel.2017.04.022","volume":"66","author":"S Inano","year":"2017","unstructured":"Inano S, Sato K, Katsuki Y, Kobayashi W, Tanaka H, Nakajima K, et al. RFWD3-mediated ubiquitination promotes timely removal of both RPA and RAD51 from DNA damage sites to facilitate homologous recombination. Mol Cell. 2017;66(5):622\u201334.e8.","journal-title":"Mol Cell"},{"issue":"8","key":"1730_CR4","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3390\/ijms18081804","volume":"18","author":"M Nepal","year":"2017","unstructured":"Nepal M, Che R, Ma C, Zhang J, Fei P. FANCD2 and DNA damage. Int J Mol Sci. 2017;18(8):1804.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1730_CR5","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1172\/JCI92069","volume":"127","author":"K Knies","year":"2017","unstructured":"Knies K, Inano S, Ram\u00edrez MJ, Ishiai M, Surrall\u00e9s J, Takata M, Schindler D. Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia. J Clin Invest. 2017;127(8):3013\u201327.","journal-title":"J Clin Invest"},{"key":"1730_CR6","doi-asserted-by":"publisher","first-page":"820273","DOI":"10.3389\/fcimb.2022.820273","volume":"12","author":"K Landelouci","year":"2022","unstructured":"Landelouci K, Sinha S, Pepin G. Type-I interferon signaling in Fanconi Anemia. Front Cell Infect Microbiol. 2022;12:820273.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"1730_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/jpm12030396","volume":"12","author":"FG Parsa","year":"2022","unstructured":"Parsa FG, Nobili S, Karimpour M, Aghdaei HA, Nazemalhosseini-Mojarad E, Mini E. Fanconi Anemia pathway in colorectal Cancer: a novel opportunity for diagnosis, prognosis and therapy. J Pers Med. 2022;12(3):396.","journal-title":"J Pers Med"},{"issue":"12","key":"1730_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.trecan.2017.10.005","volume":"3","author":"M Nepal","year":"2017","unstructured":"Nepal M, Che R, Zhang J, Ma C, Fei P. Fanconi Anemia Signaling and Cancer. Trends Cancer. 2017;3(12):840\u201356.","journal-title":"Trends Cancer"},{"issue":"3","key":"1730_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrc.2017.116","volume":"18","author":"G Nalepa","year":"2018","unstructured":"Nalepa G, Clapp DW. Fanconi anaemia and cancer: an intricate relationship. Nat Rev Cancer. 2018;18(3):168\u201385.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1730_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.hoc.2018.04.002","volume":"32","author":"SA Savage","year":"2018","unstructured":"Savage SA, Walsh MF. Myelodysplastic syndrome, acute myeloid leukemia, and Cancer surveillance in Fanconi Anemia. Hematol Oncol Clin North Am. 2018;32(4):657\u201368.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9936","key":"1730_CR11","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(13)61901-7","volume":"383","author":"L Ad\u00e8s","year":"2014","unstructured":"Ad\u00e8s L, Itzykson R, Fenaux P. Myelodysplastic syndromes. Lancet. 2014;383(9936):2239\u201352.","journal-title":"Lancet"},{"issue":"14","key":"1730_CR12","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJMra1904794","volume":"383","author":"M Cazzola","year":"2020","unstructured":"Cazzola M. Myelodysplastic syndromes. N Engl J Med. 2020;383(14):1358\u201374.","journal-title":"N Engl J Med"},{"issue":"19","key":"1730_CR13","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1056\/NEJMra0902908","volume":"361","author":"A Tefferi","year":"2009","unstructured":"Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009;361(19):1872\u201385.","journal-title":"N Engl J Med"},{"issue":"12","key":"1730_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1182\/blood.2021011694","volume":"138","author":"JE Rubnitz","year":"2021","unstructured":"Rubnitz JE, Kaspers GJL. How I treat pediatric acute myeloid leukemia. Blood. 2021;138(12):1009\u201318.","journal-title":"Blood"},{"issue":"10147","key":"1730_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","volume":"392","author":"NJ Short","year":"2018","unstructured":"Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392(10147):593\u2013606.","journal-title":"Lancet"},{"key":"1730_CR16","doi-asserted-by":"publisher","first-page":"n2026","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. Bmj. 2021;375:n2026.","journal-title":"Bmj"},{"issue":"7","key":"1730_CR17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.cell.2005.12.009","volume":"123","author":"LJ Niedernhofer","year":"2005","unstructured":"Niedernhofer LJ, Lalai AS, Hoeijmakers JH. Fanconi anemia (cross)linked to DNA repair. Cell. 2005;123(7):1191\u20138.","journal-title":"Cell"},{"issue":"23","key":"1730_CR18","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209\u201321.","journal-title":"N Engl J Med"},{"issue":"22","key":"1730_CR19","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122(22):3616\u201327. quiz 99","journal-title":"Blood"},{"issue":"5","key":"1730_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"269","key":"1730_CR21","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.","journal-title":"Sci Signal"},{"issue":"7728","key":"1730_CR22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner JW, Tognon CE, Bottomly D, Wilmot B, Kurtz SE, Savage SL, et al. Functional genomic landscape of acute myeloid leukaemia. Nature. 2018;562(7728):526\u201331.","journal-title":"Nature"},{"key":"1730_CR23","doi-asserted-by":"publisher","first-page":"100904","DOI":"10.1016\/j.blre.2021.100904","volume":"52","author":"A Gueiderikh","year":"2022","unstructured":"Gueiderikh A, Maczkowiak-Chartois F, Rosselli F. A new frontier in Fanconi anemia: from DNA repair to ribosome biogenesis. Blood Rev. 2022;52:100904.","journal-title":"Blood Rev"},{"issue":"20","key":"1730_CR24","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMra0809889","volume":"362","author":"AD D'Andrea","year":"2010","unstructured":"D'Andrea AD. Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med. 2010;362(20):1909\u201319.","journal-title":"N Engl J Med"},{"issue":"4","key":"1730_CR25","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1365-2141.2000.02450.x","volume":"111","author":"Y Xie","year":"2000","unstructured":"Xie Y, de Winter JP, Waisfisz Q, Nieuwint AW, Scheper RJ, Arwert F, et al. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells. Br J Haematol. 2000;111(4):1057\u201364.","journal-title":"Br J Haematol"},{"key":"1730_CR26","doi-asserted-by":"crossref","unstructured":"Lejman M, Dziatkiewicz I, Jurek M. Straight to the point-the novel strategies to cure pediatric AML. Int J Mol Sci. 2022;23(4):1968.","DOI":"10.3390\/ijms23041968"},{"issue":"13","key":"1730_CR27","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1182\/blood-2012-10-462440","volume":"121","author":"RB Walter","year":"2013","unstructured":"Walter RB, Othus M, Burnett AK, L\u00f6wenberg B, Kantarjian HM, Ossenkoppele GJ, et al. Significance of FAB subclassification of \"acute myeloid leukemia, NOS\" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients. Blood. 2013;121(13):2424\u201331.","journal-title":"Blood"},{"issue":"1","key":"1730_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2002-09-2781","volume":"102","author":"MW Lensch","year":"2003","unstructured":"Lensch MW, Tischkowitz M, Christianson TA, Reifsteck CA, Speckhart SA, Jakobs PM, et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. Blood. 2003;102(1):7\u201316.","journal-title":"Blood"},{"issue":"3","key":"1730_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/sj.leu.2403280","volume":"18","author":"MD Tischkowitz","year":"2004","unstructured":"Tischkowitz MD, Morgan NV, Grimwade D, Eddy C, Ball S, Vorechovsky I, et al. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Leukemia. 2004;18(3):420\u20135.","journal-title":"Leukemia"},{"issue":"2","key":"1730_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","volume":"39","author":"DL Jardim","year":"2021","unstructured":"Jardim DL, Goodman A, de Melo GD, Kurzrock R. The challenges of tumor mutational burden as an immunotherapy biomarker. Cancer Cell. 2021;39(2):154\u201373.","journal-title":"Cancer Cell"},{"key":"1730_CR31","doi-asserted-by":"publisher","first-page":"717527","DOI":"10.3389\/fimmu.2021.717527","volume":"12","author":"XM Wen","year":"2021","unstructured":"Wen XM, Xu ZJ, Jin Y, Xia PH, Ma JC, Qian W, Lin J, Qian J. Association analyses of TP53 mutation with prognosis, tumor mutational burden, and immunological features in acute myeloid leukemia. Front Immunol. 2021;12:717527.","journal-title":"Front Immunol"},{"issue":"18","key":"1730_CR32","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1182\/blood-2014-04-526293","volume":"124","author":"S Longerich","year":"2014","unstructured":"Longerich S, Li J, Xiong Y, Sung P, Kupfer GM. Stress and DNA repair biology of the Fanconi anemia pathway. Blood. 2014;124(18):2812\u20139.","journal-title":"Blood"},{"key":"1730_CR33","doi-asserted-by":"crossref","unstructured":"Ding H, Hashem H, Cabral L, Rangarajan H, Abusin G, Lazarus HM, Abu-Arja R. Azacitidine as a bridge to allogeneic hematopoietic cell transplantation in a pediatric patient with Fanconi anemia and acute myeloid leukemia. Pediatr Transplant. 2017;21(2):1\u20133.","DOI":"10.1111\/petr.12870"},{"issue":"1","key":"1730_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-4608(91)90002-C","volume":"51","author":"AD Auerbach","year":"1991","unstructured":"Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the international Fanconi Anemia registry. Cancer Genet Cytogenet. 1991;51(1):1\u201312.","journal-title":"Cancer Genet Cytogenet"},{"key":"1730_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1756-8722-2-23","volume":"2","author":"TK Gregory","year":"2009","unstructured":"Gregory TK, Wald D, Chen Y, Vermaat JM, Xiong Y, Tse W. Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics. J Hematol Oncol. 2009;2:23.","journal-title":"J Hematol Oncol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01730-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T08:07:00Z","timestamp":1700122020000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01730-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01730-5","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"assertion":[{"value":"2 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study of the SELF_FA cohort has been reviewed and approved by the Clinical Research Ethics Committee of Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences [NI2020009-EC-1]. Because this study is retrospective, the Clinical Research Ethics Committee of Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences, has waived the informed consent. All methods were carried out following the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}